1st Quarter - Report

PODESTA GROUP, INC. for GILEAD SCIENCES

Period 1st Quarter 2011 Filed Apr 20, 2011 Signed by Kimberley Fritts, CEO

Official filing
Firm
PODESTA GROUP, INC.
Client
GILEAD SCIENCES
Income
$90,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HIV/AIDS testing and treatment; HIV/AIDS technology transfer and patent rights. HIV/AIDS funding; Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs. Federal Employees Health Benefits Program coverage

LobbyistCovered position, as disclosed
ARANTHAN JONES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

HIV/AIDS testing and treatment; HIV/AIDS technology transfer and patent rights. HIV/AIDS funding; Patient Protection and Affordable Care Act implementation. Hepatitis funding for screening and linkage to care programs.

LobbyistCovered position, as disclosed
ARANTHAN JONES —

Contacted: SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

HIV/AIDS testing and treatment. HIV/AIDS technology transfer andpatent rights. HIV/AIDS funding. Patient Protection and Affordable Care Act implementation.

LobbyistCovered position, as disclosed
ARANTHAN JONES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.